A Purpose-driven Mission with Impact

A Purpose-driven Mission with Impact

Advancing the Future of
Wound Care Support

Engineered by Doctor Dustin Williams, Ph.D. Purgo Scientific is comprised of a carefully selected board of directors, individually chosen for their experience, knowledge, and passion for developing a sustainable, localized drug delivery device to combat the biofilm infection crisis plaguing orthopedic surgery.

Advancing the 
Future of Wound 
Care Support

Engineered by Doctor Dustin Williams, Ph.D. Purgo Scientific is comprised of a carefully selected board of directors, individually chosen for their experience, knowledge, and passion for developing a sustainable, localized drug delivery device to combat the biofilm infection crisis plaguing orthopedic surgery.

Advancing the 
Future of Wound Care Support

Engineered by Doctor Dustin Williams, Ph.D. Purgo Scientific is comprised of a carefully selected board of directors, individually chosen for their experience, knowledge, and passion for developing a sustainable, localized drug delivery device to combat the biofilm infection crisis plaguing orthopedic surgery.

THE INVENTOR 

Dustin Williams, PhD

Dustin Williams, PhD

Inventor, 13-year research scientist with VA and University of Utah

Developed new prosthetic legs for soldiers and veterans.

Lead scientist in research to prevent painful bone pathology after blast-related trauma.

Developing technologies to treat and prevent infection in battlefield wounds.

Purgo Scientific, a sub-awardee of the grant, formed to make pouch available for everyone suffering from Surgical Site Infection.

Conceived Purgo Pouch to solve problem of Surgical Site Infection for Wounded Warriors and trauma patients.

Dustin Williams, PhD

Dustin Williams, PhD

Inventor, 13-year research scientist with VA and University of Utah

Developed new prosthetic legs for soldiers and veterans.

Lead scientist in research to prevent painful bone pathology after blast-related trauma.

Developing technologies to treat and prevent infection in battlefield wounds.

Purgo Scientific, a sub-awardee of the grant, formed to make pouch available for everyone suffering from Surgical Site Infection.

Conceived Purgo Pouch to solve problem of Surgical Site Infection for Wounded Warriors and trauma patients.

Dustin Williams, PhD

Inventor, 13-year research scientist with VA and University of Utah

Developed new prosthetic legs for soldiers and veterans.

Lead scientist in research to prevent painful bone pathology after blast-related trauma.

Developing technologies to treat and prevent infection in battlefield wounds.

Purgo Scientific, a sub-awardee of the grant, formed to make pouch available for everyone suffering from Surgical Site Infection.

Conceived Purgo Pouch to solve problem of Surgical Site Infection for Wounded Warriors and trauma patients.

Dustin Williams, PhD

PURGO TEAM

Leading The Science of Drug Delivery

Michael Benjamin

Position: Executive Chairman of the Board
(CEO)
Categories: Team

Experience

  • President – Benjamin Enterprises, A technology & resource development holding company.
  • Past President and CEO – Desert Research Corporation the for-profit technology transfer arm of the Desert Research Foundation.
  • President – Palomino Farms, an environmentally focused farming operation.
  • Founder, President & CEO, retired Pioneer Crossing Casinos.
  • Former Executive Board Member Nevada Commission on Sports.
  • Article 6 Commission Board Member Nevada Supreme Court.

Michael Benjamin

Executive Chairman of the Board
(CEO)

Experience President – Benjamin Enterprises, A technology & resource development...

Dustin Williams, PhD

Position: Inventor, 13-year research scientist with VA and U of U, Co-founder
Categories: Dustin

Experience

  • Ph.D. – Bioengineering from the University of Utah. B.S. in Microbiology from Weber State University.
  • Associate Professor in the Department of Orthopaedics at the University of Utah.
  • Director of the Bone and Biofilm Research Lab.

Dustin Williams, PhD

Inventor, 13-year research scientist with VA and U of U, Co-founder

Experience Ph.D. – Bioengineering from the University of Utah. B.S....

Susan Winckler, RHp, Esq

Position: Board Director
Categories: Team

Experience

  • CEO – Reagan-Udall Foundation for the Food and Drug Administration
  • Former Chief of Staff U.S. Food and Drug Administration
  • Former President of Leavitt Partner Solutions
  • Former CEO Food & Drug Institute

Susan Winckler, RHp, Esq

Board Director

Experience CEO – Reagan-Udall Foundation for the Food and Drug...

Stephanie Morley, DVM

Position: Board Member, President, Vetlen
Categories: Team
Stephanie Morley, DVM: President, Vetlen

Experience

  • 2003 – She practiced small animal medicine in New Mexico and Michigan before transitioning into laboratory animal medicine.
  • 2006 – Vice President of Operations at MPI Research (now a Charles River company), largest single site contract research organization in the world.
  • 2013 – She transitioned to academia working at the University of Michigan Medical School as Associate Director of Business Development for Fast Forward Medical Innovation.
  • 2015 – Co-founder of Zomedica. She leveraged this experience for the veterinary sector by identifying new technologies that could advance veterinary practice.
  • 2016 – Zomedica listed on the Toronto Stock Exchange Venture Exchange.
  • 2017 – listed onto the NYSE American in 2017.
  • 2021 – Created an advisory practice focused on working with founders, in and out of the biomedical sector, to develop business strategy, support fundraising efforts and provide personal guidance as they navigate the choppy waters of leading a start-up.

Stephanie Morley, DVM

Board Member, President, Vetlen

Experience 2003 – She practiced small animal medicine in New...

David Greenberg

Position: Science Advisory Board Member
Categories: Team
David Greenberg:

Experience

  • A board-certified Infectious Diseases physician-scientist.
  • Professor of Infectious Diseases and Microbiology at UT Southwestern Medical Center.
  • Distinguished Teaching Professor at UT Southwestern Medical Center.
  • Past recipient of the Regents’ Outstanding Teaching Award for the UT System.
  • Fellow in the Infectious Diseases Association of America.
  • Nationally known biofilm and biofilm-associated implant researcher.

David Greenberg

Science Advisory Board Member

Experience A board-certified Infectious Diseases physician-scientist. Professor of Infectious Diseases...

Business Milestones

2016 & 2017

Invented by Dustin Williams PhD Associate Professor at the University of Utah and Director of the Bone and Biofilm Research Lab and Nicholas Ashton PhD.

Secured and Executed the Exclusive License Agreement with University of Utah Research Foundation.

2018 & 2019

Raised $350,000 of seed capital.

Completed business plan.

Applied for DOD grant.

Started developing prototypes.

Implemented IP strategy.

2016 & 2017

Invented by Dustin Williams PhD Associate Professor at the University of Utah and Director of the Bone and Biofilm Research Lab and Nicholas Ashton PhD.

Secured and Executed the Exclusive License Agreement with University of Utah Research Foundation.

2018 & 2019

Raised $350,000 of seed capital.

Started developing prototypes.

Completed business plan.

Implemented IP strategy.

Applied for DOD grant.

2016 & 2017

Invented by Dustin Williams PhD Associate Professor at the University of Utah and Director of the Bone and Biofilm Research Lab and Nicholas Ashton PhD.

Secured and Executed the Exclusive License Agreement with University of Utah Research Foundation.

2018 & 2019

Raised $350,000 of seed capital.

Completed business plan.

Applied for DOD grant.

Started developing prototypes.

Implemented IP strategy.

2020

AWARDED $4,260,000 in funded grants from an RFP from the Department of Defense for pouch development for Wounded Warriors.

USPTO issued patent for “Therapeutic Delivery Device.”

Prior to issuance, Purgo filed three patent continuations for new innovations.

Began initial sheep study.

2021

Prototype completed USING all medical grade components.

Continued sheep studies to confirm the efficacy of the Pouch.

Raised $850,000 in ADDITIONAL funding through the sale of Series C Units.

2020

AWARDED $4,260,000 in funded grants from an RFP from the Department of Defense for pouch development for Wounded Warriors.

USPTO issued patent for “Therapeutic Delivery Device.”

Prior to issuance, Purgo filed three patent continuations for new innovations.

Began initial sheep study.

2021

Prototype completed USING all medical grade components.

Continued sheep studies to confirm the efficacy of the Pouch.

Raised $850,000 in ADDITIONAL funding through the sale of Series C Units.

Commercialization Path

Creating Value for Investors

2022

Completed

  • Commence FDA clearance process.
  • Initiated 60+ sheep study.
  • Filing additional patent applications.
  • Filing for FDA clearance.
  • Raising additional funds through grants.
  • Sale of additional equity.
  • Complete private placement of series C units.
  • Prepping for clinical trials.

2022
Completed
2023

  • Begin discussions with Medicare / Medicaid and private insurers to approve reimbursement for procedure to place and remove the Pouch.
  • Develop relationships with hospitals that could be direct payers for the Pouch.
  • Prepare clinical trials strategy for Pouch clearance from the FDA if necessary.
  • Prepare strategy and establish relationships with surgeons to participate in the clinical trials.
  • Clinical trials begin.

2023
2024

  • Clinical trials completed.
  • Obtain FDA clearance.
  • Obtain reimbursement codes from the AMA. ICD10 World Health Organization.
  • Obtain CPT codes from American Medical Association.
    Launch the Purgo Pouch for surgical use.

2024

Commercialization Path

Creating Value for Investors

2022

  • Commence FDA clearance process.
  • Initiated 60+ sheep study.
  • Filing additional patent applications.
  • Filing for FDA clearance.
  • Raising additional funds through grants.
  • Sale of additional equity.
  • Complete private placement of series C units.
  • Prepping for clinical trials.

2022
2023

  • Begin discussions with Medicare / Medicaid and private insurers to approve reimbursement for procedure to place and remove the Pouch.
  • Develop relationships with hospitals that could be direct payers for the Pouch.
  • Prepare clinical trials strategy for Pouch clearance from the FDA if necessary.
  • Prepare strategy and establish relationships with surgeons to participate in the clinical trials.
  • Clinical trials begin.

2023
2024

  • Clinical trials completed.
  • Obtain FDA clearance.
  • Obtain reimbursement codes from the AMA. ICE10 World Health Organization. (Develop Stratigy)
  • Obtain CPT codes from American Medical Association.
    Launch the Purgo Pouch for surgical use.

2024